Historical salary details - Mr. Julian S. Gangolli, Independent Director, Krystal Biotech Inc
Mr. Julian S. Gangolli is the Independent Director of Krystal Biotech Inc. They also hold 1 other positions in and Outlook Therapeutics Inc.
Mr. Julian S. Gangolli
Independent Director
$ 782.7 K
Gross Remuneration
-
Current Company
Krystal Biotech Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Krystal Biotech Inc | Independent Director | 670.2 K | - |
| 2024 | Outlook Therapeutics Inc | Independent Director | 112.5 K | 0.0 % |
| 2023 | Revance Therapeutics Inc | Independent Director | 305.0 K | 6.3 % |
| 2023 | Outlook Therapeutics Inc | Independent Director | 112.5 K | -0.1 % |
| 2022 | Krystal Biotech Inc | Independent Director | 359.8 K | 4.4 % |
| 2022 | Revance Therapeutics Inc | Independent Director | 287.0 K | -1.5 % |
| 2022 | Outlook Therapeutics Inc | Independent Director | 112.6 K | 0.1 % |
| 2021 | Krystal Biotech Inc | Independent Director | 344.5 K | 52.1 % |
| 2021 | Revance Therapeutics Inc | Independent Director | 291.3 K | -2.4 % |
| 2021 | Outlook Therapeutics Inc | Independent Director | 112.5 K | -39.6 % |
| 2020 | Revance Therapeutics Inc | Independent Director | 298.4 K | 73.2 % |
| 2020 | Krystal Biotech Inc | Independent Director | 226.4 K | 554.7 % |
| 2020 | Outlook Therapeutics Inc | Independent Director | 186.4 K | - |
| 2019 | Revance Therapeutics Inc | Independent Director | 172.3 K | -25.3 % |
| 2019 | Krystal Biotech Inc | Independent Director | 34.6 K | - |
| 2018 | Revance Therapeutics Inc | Independent Director | 230.5 K | 26.3 % |
| 2018 | Krystal Biotech Inc | Independent Director | - | - |
| 2017 | Revance Therapeutics Inc | Independent Director | 182.5 K | 11.5 % |
| 2016 | Revance Therapeutics Inc | Independent Director | 163.7 K | - |